Better Outcomes With Early HETs in Pediatric-Onset MS
Early initiation of HET in pediatric-onset MS was linked to slower progression to disability compared to treatment with low-efficacy therapy or no treatment.
Stay updated with breaking news from Stem Cell Therapy. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Early initiation of HET in pediatric-onset MS was linked to slower progression to disability compared to treatment with low-efficacy therapy or no treatment.
This article sheds light on the function of stem cells in cardiac care as well as the exciting new directions in heart disease treatment. Read More
The longest overall survival of nearly 8-10 years was with autologous stem cell transplantation.
Autism is a complex disorder that affects millions of people worldwide. Many treatments are emerging that hold the potential to treat autism and give autism...
BioRestorative Therapies Presents Promising Data at Orthopaedic Research ...